Results 21 to 30 of about 82,050 (251)

Editöre Mektup - Red cell distribution width and contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention

Türk Kardiyoloji Derneği Arşivi, 2016
red cell distribution width and contrast-induced nephropathy in patients underwent primary percutaneous coronary intervention red cell distribution width and contrast-induced nephropathy in patients underwent primary percutaneous coronary intervention ...
Somsri Wiwanitkit, Viroj Wiwanitkit
doaj   +1 more source

Thrombocytopenia in a Patient Undergoing Primary Percutaneous Coronary Intervention

Folia Medica Indonesiana, 2021
Thrombocytopenia is a common abnormality in patients presenting with acute coronary syndrome. Baseline thrombocytopenia in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention is associated with early ...
Yudi Her Oktaviono, Feranti Meuthia
doaj   +1 more source

TWO YEAR OUTCOME OF PRIMARY PERCUTANEOUS CORONARY IN PAKISTAN NAVAL SHIP SHIFA CARDIAC CENTER

Pakistan Armed Forces Medical Journal, 2021
Objective: To determine the in-hospital outcomes of primary percutaneous coronary intervention approach in a tertiary care cardiac center. Study Design: Retrospective observational descriptive study.
Safina Shabbir, Muhammad Nadir Khan, Kumail Abbas Khan, Waqas Khalid, Jawad Abbas, Shahid Abbas, Amer Rauf   +6 more
doaj   +2 more sources

Rationale and design of EXPLORE: a randomized, prospective, multicenter trial investigating the impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction

Trials, 2010
Background In the setting of primary percutaneous coronary intervention, patients with a chronic total occlusion in a non-infarct related artery were recently identified as a high-risk subgroup.
Tuseth Vegard, Olivecrona Göran K, Strauss Bradley H, Bax Matthijs, Barbato Emanuele, Suttorp Maarten J, Koolen Jacques J, Verouden Niels J, Hoebers Loes P, Claessen Bimmer E, van der Schaaf René J, Glogar Dietmar, Råmunddal Truls, Tijssen Jan G, Piek Jan J, Henriques José PS   +15 more
doaj   +1 more source

Impact of the Total Ischemia Time on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Anatolian Journal of Cardiology, 2022
Background: No-reflow phenomenon after primary percutaneous coronary intervention is a common condition affecting the outcomes; therefore, studying its predictive factors is helpful in identifying patients at high risk.
Mohamed Khalfallah, Amany Allaithy, Dina Abdelsalam   +2 more
doaj   +1 more source

A rare complication of primary percutaneous coronary intervention: Left atrial dissection and hematoma

Research in Cardiovascular Medicine, 2016
Introduction: Left atrial dissection and hematoma are a life threatening condition, which are rarely seen following percutaneous coronary interventions.
M Fikri Yapici, Nihat Ozer, Arda Sanli Okmen, Altug Sagir, Tarik Bugra Denizalti, Azmi Ozler   +5 more
doaj   +1 more source

COMPARISON OF EFFECT OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION WITH STREPTOKINASE IN ACUTE ST ELEVATION MYOCARDIAL INFARCTION (STEMI) ON LEFT VENTRICULAR FUNCTION AFTER 3 MONTHS

Pakistan Armed Forces Medical Journal, 2020
Objective: To assess the left ventricular function three months after the primary percutaneous coronary intervention versus Streptokinase in ST elevation myocardial infarction. Study Design: Prospective comparative study.
Saleha Abbas, Abdul Hameed Siddiqui, Ammar Cheema, Ayesha Abbas, Sadaf Khan, Anum Fatima Janjua, Farhan Tuyyab   +6 more
doaj   +1 more source

Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration

Trials, 2009
Background Administration of abciximab during primary percutaneous coronary intervention is an effective adjunctive therapy in the treatment of patients with ST-segment elevation myocardial infarction.
Gu Youlan L, Fokkema Marieke L, Kampinga Marthe A, de Smet Bart JGL, Tan Eng S, van den Heuvel Ad FM, Zijlstra Felix   +6 more
doaj   +1 more source

Accelerate and Decelerate in Primary Percutaneous Coronary Intervention

JACC: Cardiovascular Interventions, 2016
ST-segment elevation myocardial infarction (STEMI) is considered a major contributor to global mortality and morbidity. The final necrotic infarct size has been identified as one of the major predictors of the clinical outcome after STEMI.
Piek, Jan J., van Lavieren, Martijn A.
openaire   +2 more sources

Feasibility and Safety of Distal Radial Artery Access in Anatomical Snuffbox for Coronary Angiography and Coronary Intervention

Journal of Nepal Health Research Council, 2020
Background: There is limited data on feasibility and safety of coronary interventions performed using radial artery at anatomical snuffbox as vascular access point in South Asian region. Our study attempts to evaluate the feasibility and safety
Arun Maskey, Birat Krishna Timalsena, Sheikh Aslam, Rabindra Pandey, Madhu Roka, Shreya Bhandari, Himamshu Nepal   +6 more
doaj   +1 more source